Anthos Therapeutics

About:

Anthos Therapeutics is a biopharmaceutical company that specializes in the treatment of cardiovascular and metabolic diseases.

Website: https://anthostherapeutics.com

Twitter/X: Anthos_Tx

Top Investors: Novartis, Blackstone Life Sciences, Novo Seeds

Description:

Anthos Therapeutics is a biopharmaceutical company that specializes in the treatment of cardiovascular and metabolic diseases. The company was founded by a world-class executive team with extensive experience in the development and commercialization of CVM disease therapies.

Total Funding Amount:

$250M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2018-01-01

Contact Email:

info(AT)anthostherapeutics.com

Founders:

Jonathan Freeman

Number of Employees:

11-50

Last Funding Date:

2019-02-27

IPO Status:

Private

Industries:

© 2025 bioDAO.ai